Page last updated: 2024-11-02

oxyphenbutazone and Erysipelas

oxyphenbutazone has been researched along with Erysipelas in 2 studies

Oxyphenbutazone: A non-steroidal anti-inflammatory drug. Oxyphenbutazone eyedrops have been used abroad in the management of postoperative ocular inflammation, superficial eye injuries, and episcleritis. (From AMA, Drug Evaluations Annual, 1994, p2000) It had been used by mouth in rheumatic disorders such as ankylosing spondylitis, osteoarthritis, and rheumatoid arthritis but such use is no longer considered justified owing to the risk of severe hematological adverse effects. (From Martindale, The Extra Pharmacopoeia, 30th ed, p27)
oxyphenbutazone : A metabolite of phenylbutazone obtained by hydroxylation at position 4 of one of the phenyl rings. Commonly used (as its hydrate) to treat pain, swelling and stiffness associated with arthritis and gout, it was withdrawn from the market 1984 following association with blood dyscrasis and Stevens-Johnson syndrome.

Erysipelas: An acute infection of the skin caused by species of STREPTOCOCCUS. This disease most frequently affects infants, young children, and the elderly. Characteristics include pink-to-red lesions that spread rapidly and are warm to the touch. The commonest site of involvement is the face.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
FERNANDEZSANZ, S2

Other Studies

2 other studies available for oxyphenbutazone and Erysipelas

ArticleYear
[ERYSIPELAS AND TANDERIL; CLINICAL NOTE].
    Hispalis medica; revista sevillana de medicina y cirugia, 1964, Volume: 21

    Topics: Drug Therapy; Erysipelas; Oxyphenbutazone

1964
[ERYSIPELAS AND TANDEARIL].
    Revista clinica espanola, 1964, Nov-15, Volume: 95

    Topics: Drug Therapy; Erysipelas; Humans; Oxyphenbutazone

1964